Andrew Elagizi

2.3k total citations · 3 hit papers
23 papers, 1.5k citations indexed

About

Andrew Elagizi is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Andrew Elagizi has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 5 papers in Complementary and alternative medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Andrew Elagizi's work include Cardiovascular Function and Risk Factors (10 papers), Cardiovascular Disease and Adiposity (8 papers) and Fatty Acid Research and Health (5 papers). Andrew Elagizi is often cited by papers focused on Cardiovascular Function and Risk Factors (10 papers), Cardiovascular Disease and Adiposity (8 papers) and Fatty Acid Research and Health (5 papers). Andrew Elagizi collaborates with scholars based in United States, Finland and Norway. Andrew Elagizi's co-authors include Carl J. Lavie, Salvatore Carbone, Richard V. Milani, Sergey Kachur, Ambarish Pandey, Francisco B. Ortega, James H. O’Keefe, Mohammad Shadab Siddiqui, Hayley Billingsley and Justin M. Canada and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Andrew Elagizi

21 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases

2018 494 citations Andrew Elagizi, Sergey Kachur et al. Progress in Cardiovascular Diseases profile →
<p>Obesity paradox in cardiovascular disease: where do we stand?</p>

2019 234 citations Salvatore Carbone, Justin M. Canada et al. Vascular Health and Risk Management profile →
Estrogen and cardiovascular disease

2024 39 citations James H. O’Keefe, Andrew Elagizi et al. Progress in Cardiovascular Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Elagizi United States	13	530	420	260	243	181	23	1.5k
Heno Ferreira Lopes Brazil	20	492 0.9×	569 1.4×	221 0.8×	208 0.9×	215 1.2×	67	1.4k
Toba Kazemi Iran	22	360 0.7×	288 0.7×	271 1.0×	254 1.0×	236 1.3×	197	1.8k
Marcelo Perim Baldo Brazil	24	633 1.2×	214 0.5×	290 1.1×	285 1.2×	154 0.9×	88	1.3k
Johannes M. Van Rooyen South Africa	26	965 1.8×	251 0.6×	256 1.0×	360 1.5×	255 1.4×	122	1.9k
Hugo W. Huisman South Africa	28	1.0k 1.9×	325 0.8×	308 1.2×	387 1.6×	316 1.7×	125	2.1k
Marjorie Bastien Canada	11	412 0.8×	394 0.9×	220 0.8×	158 0.7×	230 1.3×	19	1.1k
Xizhuo Sun China	21	362 0.7×	313 0.7×	343 1.3×	397 1.6×	285 1.6×	55	1.4k
Rudolph Schutte South Africa	29	1.0k 1.9×	316 0.8×	232 0.9×	352 1.4×	323 1.8×	119	2.3k
Nazaré Souza Bissoli Brazil	24	352 0.7×	301 0.7×	198 0.8×	514 2.1×	93 0.5×	102	1.6k
Leon I. Igel United States	16	297 0.6×	525 1.3×	231 0.9×	369 1.5×	148 0.8×	30	1.4k

Countries citing papers authored by Andrew Elagizi

Since Specialization

Citations

This map shows the geographic impact of Andrew Elagizi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Elagizi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Elagizi more than expected).

Fields of papers citing papers by Andrew Elagizi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Elagizi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Elagizi. The network helps show where Andrew Elagizi may publish in the future.

Co-authorship network of co-authors of Andrew Elagizi

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Elagizi. A scholar is included among the top collaborators of Andrew Elagizi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Elagizi. Andrew Elagizi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qamruddin, Salima, Fang Chen, Sergey Kachur, et al.. (2025). Peak myocardial work assessment to detect coronary ischemia during dobutamine stress echocardiography. Frontiers in Cardiovascular Medicine. 12. 1556991–1556991. 1 indexed citations

O’Keefe, James H., et al.. (2024). Estrogen and cardiovascular disease. Progress in Cardiovascular Diseases. 84. 60–67. 39 indexed citations breakdown →

O’Keefe, Evan L., et al.. (2024). Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases. Progress in Cardiovascular Diseases. 84. 19–26. 12 indexed citations

Stewart, Merrill H., Andrew Elagizi, & Yvonne Gilliland. (2023). Imaging of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Current Opinion in Cardiology. 38(5). 405–414. 1 indexed citations

Elagizi, Andrew, et al.. (2023). Testosterone and cardiovascular health. European Heart Journal. 45(2). 139–141. 6 indexed citations

Rodríguez, Daniel, Carl J. Lavie, Andrew Elagizi, & Richard V. Milani. (2022). Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health. Nutrients. 14(23). 5146–5146. 37 indexed citations

Carbone, Salvatore, Carl J. Lavie, Andrew Elagizi, Ross Arena, & Héctor O. Ventura. (2022). The Impact of Obesity in Heart Failure. Cardiology Clinics. 40(2). 209–218. 12 indexed citations

Elagizi, Andrew, Carl J. Lavie, Evan L. O’Keefe, et al.. (2021). An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health. Nutrients. 13(1). 204–204. 124 indexed citations

Elagizi, Andrew, Sergey Kachur, Salvatore Carbone, Carl J. Lavie, & Steven N. Blair. (2020). A Review of Obesity, Physical Activity, and Cardiovascular Disease. Current Obesity Reports. 9(4). 571–581. 172 indexed citations

10.

Kachur, Sergey, et al.. (2020). CHANGES IN OXYGEN CONSUMPTION (NOT ANAEROBIC METABOLISM) DRIVE OUTCOMES AFTER EXERCISE THERAPY IN CARDIAC REHABILITATION. Journal of the American College of Cardiology. 75(11). 1971–1971.

11.

Elagizi, Andrew, Salvatore Carbone, Carl J. Lavie, Mandeep R. Mehra, & Héctor O. Ventura. (2020). Implications of obesity across the heart failure continuum. Progress in Cardiovascular Diseases. 63(5). 561–569. 27 indexed citations

12.

Carbone, Salvatore, et al.. (2019). Obesity paradox in cardiovascular disease: where do we stand?. SHILAP Revista de lepidopterología. 17 indexed citations

13.

Carbone, Salvatore, Carl J. Lavie, Andrew Elagizi, Ross Arena, & Héctor O. Ventura. (2019). The Impact of Obesity in Heart Failure. Heart Failure Clinics. 16(1). 71–80. 53 indexed citations

14.

O’Keefe, Evan L., William S. Harris, James J. DiNicolantonio, et al.. (2019). Sea Change for Marine Omega-3s. Mayo Clinic Proceedings. 94(12). 2524–2533. 21 indexed citations

15.

Carbone, Salvatore, Justin M. Canada, Hayley Billingsley, et al.. (2019). <p>Obesity paradox in cardiovascular disease: where do we stand?</p>. Vascular Health and Risk Management. Volume 15. 89–100. 234 indexed citations breakdown →

16.

Lavie, Carl J., Salvatore Carbone, Sergey Kachur, Evan L. O’Keefe, & Andrew Elagizi. (2019). Effects of Physical Activity, Exercise, and Fitness on Obesity-Related Morbidity and Mortality. Current Sports Medicine Reports. 18(8). 292–298. 43 indexed citations

17.

Elagizi, Andrew, Sergey Kachur, Carl J. Lavie, et al.. (2018). An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases. Progress in Cardiovascular Diseases. 61(2). 142–150. 494 indexed citations breakdown →

18.

Lavie, Carl J., Andrew Elagizi, Sergey Kachur, Salvatore Carbone, & Edward Archer. (2018). Weighing in on obesity prevention and cardiovascular disease prognosis. Journal of Laboratory and Precision Medicine. 3. 85–85. 3 indexed citations

19.

Elagizi, Andrew, Carl J. Lavie, Keri Marshall, et al.. (2018). Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health: A Comprehensive Review. Progress in Cardiovascular Diseases. 61(1). 76–85. 64 indexed citations

20.

Elagizi, Andrew, Tobias Köhler, & Carl J. Lavie. (2017). Testosterone and Cardiovascular Health. Mayo Clinic Proceedings. 93(1). 83–100. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact